Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-22

FDA Approved: REGOXIDINE (FOR WOMEN) — Original Application (INNOVUS PHARMACEUTICALS, INC.)

View source ↗

Summary

FDA approves REGOXIDINE for Women, a minoxidil topical product, as an original generic application by Innovus Pharmaceuticals (ANDA 218616).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REGOXIDINE (FOR WOMEN) (MINOXIDIL)

Snippet

ORIG AP for REGOXIDINE (FOR WOMEN) (MINOXIDIL)